Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Biochimica Et Biophysica Acta
|
February 7, 2013
Bone marrow contributions to fibrosis
Alison Mackinnon, Stuart Forbes
Methods in Molecular Medicine
|
November 6, 2002
[D-Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism
Alison MacKinnon, Tariq Sethi
Chest
|
May 8, 2008
Targeting growth factors in lung cancer
Philip S Hodkinson, Alison Mackinnon, Tariq Sethi
International Journal of Clinical Pharmacy
|
July 20, 2019
Stakeholders views of medicines administration by pharmacy technicians on mental health inpatient wards
Joanne Woodward, Alison MacKinnon, Richard Neil Keers
Transplantation
|
February 7, 2012
Tubular atrophy and interstitial fibrosis after renal transplantation is dependent on galectin-3
Zexu Dang, Alison MacKinnon, Lorna P Marson, et al.
Biochemical Pharmacology
|
July 20, 2005
Thrombin induces DNA synthesis and phosphoinositide hydrolysis in airway smooth muscle by activation of distinct receptors
Trevor R Walker, Karen A Cadwallader, Alison MacKinnon, et al.
International Journal of Cancer
|
April 26, 2012
Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate
Wei Wang, Philip Hodkinson, Fiona McLaren, et al.
ACS Central Science
|
October 6, 2017
Chemical Modulation of <i>in Vivo</i> Macrophage Function with Subpopulation-Specific Fluorescent Prodrug Conjugates
Antonio Fernandez, Matthieu Vermeren, Duncan Humphries, et al.
Journal of Medicinal Chemistry
|
August 9, 2016
A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model
Vishal K Rajput, Alison MacKinnon, Santanu Mandal, et al.
Journal of Medicinal Chemistry
|
September 26, 2022
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease
Fredrik R Zetterberg, Alison MacKinnon, Thomas Brimert, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Biochimica Et Biophysica Acta
|
February 7, 2013
Bone marrow contributions to fibrosis
Alison Mackinnon, Stuart Forbes
Methods in Molecular Medicine
|
November 6, 2002
[D-Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism
Alison MacKinnon, Tariq Sethi
Chest
|
May 8, 2008
Targeting growth factors in lung cancer
Philip S Hodkinson, Alison Mackinnon, Tariq Sethi
International Journal of Clinical Pharmacy
|
July 20, 2019
Stakeholders views of medicines administration by pharmacy technicians on mental health inpatient wards
Joanne Woodward, Alison MacKinnon, Richard Neil Keers
Transplantation
|
February 7, 2012
Tubular atrophy and interstitial fibrosis after renal transplantation is dependent on galectin-3
Zexu Dang, Alison MacKinnon, Lorna P Marson, et al.
Biochemical Pharmacology
|
July 20, 2005
Thrombin induces DNA synthesis and phosphoinositide hydrolysis in airway smooth muscle by activation of distinct receptors
Trevor R Walker, Karen A Cadwallader, Alison MacKinnon, et al.
International Journal of Cancer
|
April 26, 2012
Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate
Wei Wang, Philip Hodkinson, Fiona McLaren, et al.
ACS Central Science
|
October 6, 2017
Chemical Modulation of <i>in Vivo</i> Macrophage Function with Subpopulation-Specific Fluorescent Prodrug Conjugates
Antonio Fernandez, Matthieu Vermeren, Duncan Humphries, et al.
Journal of Medicinal Chemistry
|
August 9, 2016
A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model
Vishal K Rajput, Alison MacKinnon, Santanu Mandal, et al.
Journal of Medicinal Chemistry
|
September 26, 2022
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease
Fredrik R Zetterberg, Alison MacKinnon, Thomas Brimert, et al.
Page
of 2